SPIRE HEALTHCARE GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.82 EUR | -3.42% |
|
-6.00% | +6.82% |
| 05-09 | Spire Healthcare touts strong trading, backs outlook | AN |
| 05-09 | Spire Healthcare Reiterates FY24 Guidance | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +6.82% | 1.21B | - | ||
| -26.36% | 14.93B | B+ | ||
| -1.80% | 11.81B | B | ||
| +3.65% | 11.67B | B+ | ||
| +8.83% | 10.68B | B+ | ||
| +26.35% | 8.49B | B | ||
| -8.21% | 7.3B | A- | ||
| +6.02% | 6.72B | B- | ||
| +9.84% | 6.48B | D | ||
| +19.81% | 4.54B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SPI Stock
- S00 Stock
- Ratings Spire Healthcare Group plc
